4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001348362-25-000011
Options or other derivatives
- Chief Executive Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
CHRISTOPHER RICHARD · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-15 | Grant or award : show line 1 in the form Stock Options | +150,000 | 350,000 | D |
Loading xslF345X05/primary_doc.xml…